Reuters: Bill Smead discusses Pharma earnings (1/29/2013)
Pfizer, Lilly beat Street; generics take toll By Bill Berkrot & Ransdell Pierson Reuters For more information go to wwwww.chicagotribune.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee
January 30, 2013
